

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.87436092 |
| 2 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.14689566 |
| 3 | rhodopsin mediated signaling pathway (GO:0016056) | 5.04120272 |
| 4 | retinal cone cell development (GO:0046549) | 4.71456438 |
| 5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.66200337 |
| 6 | T cell lineage commitment (GO:0002360) | 4.62413950 |
| 7 | NIK/NF-kappaB signaling (GO:0038061) | 4.29295636 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 4.21553022 |
| 9 | B cell homeostasis (GO:0001782) | 4.11223051 |
| 10 | photoreceptor cell development (GO:0042461) | 4.10446157 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05809551 |
| 12 | activation of MAPKKK activity (GO:0000185) | 4.03446830 |
| 13 | nuclear pore complex assembly (GO:0051292) | 3.92737982 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.90116846 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.90116846 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.90116846 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.90116846 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.90116846 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.90116846 |
| 20 | eye photoreceptor cell development (GO:0042462) | 3.87850416 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 3.85422822 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.81769854 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.81769854 |
| 24 | response to type I interferon (GO:0034340) | 3.79921278 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.68160807 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66674187 |
| 27 | photoreceptor cell maintenance (GO:0045494) | 3.66170064 |
| 28 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.59642186 |
| 29 | B cell proliferation (GO:0042100) | 3.54539238 |
| 30 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.51254731 |
| 31 | retinal rod cell development (GO:0046548) | 3.49413797 |
| 32 | T cell migration (GO:0072678) | 3.47185168 |
| 33 | mitotic chromosome condensation (GO:0007076) | 3.46093122 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43365064 |
| 35 | phototransduction (GO:0007602) | 3.39959656 |
| 36 | detection of light stimulus involved in visual perception (GO:0050908) | 3.36767176 |
| 37 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.36767176 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35952163 |
| 39 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.34948818 |
| 40 | regulation of RNA export from nucleus (GO:0046831) | 3.33294047 |
| 41 | positive regulation of macrophage cytokine production (GO:0060907) | 3.30881671 |
| 42 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.28075913 |
| 43 | DNA unwinding involved in DNA replication (GO:0006268) | 3.25935661 |
| 44 | response to host (GO:0075136) | 3.25522402 |
| 45 | response to host defenses (GO:0052200) | 3.25522402 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.25522402 |
| 47 | phototransduction, visible light (GO:0007603) | 3.23930206 |
| 48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.22109894 |
| 49 | synaptic vesicle maturation (GO:0016188) | 3.21852017 |
| 50 | detection of light stimulus (GO:0009583) | 3.21362097 |
| 51 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.18311881 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16186642 |
| 53 | response to host immune response (GO:0052572) | 3.16186642 |
| 54 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.15051359 |
| 55 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.14563315 |
| 56 | germinal center formation (GO:0002467) | 3.14379621 |
| 57 | myeloid dendritic cell activation (GO:0001773) | 3.12128654 |
| 58 | growth hormone receptor signaling pathway (GO:0060396) | 3.08818129 |
| 59 | nuclear pore organization (GO:0006999) | 3.08789304 |
| 60 | detection of visible light (GO:0009584) | 3.08428254 |
| 61 | glutamate secretion (GO:0014047) | 3.08150258 |
| 62 | positive regulation of interleukin-2 production (GO:0032743) | 3.07449999 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06305058 |
| 64 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.01733671 |
| 65 | T-helper 1 type immune response (GO:0042088) | 2.97434567 |
| 66 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.96635410 |
| 67 | response to peptidoglycan (GO:0032494) | 2.94108224 |
| 68 | B cell mediated immunity (GO:0019724) | 2.94048133 |
| 69 | regulation of histone H3-K9 methylation (GO:0051570) | 2.92726382 |
| 70 | protein-chromophore linkage (GO:0018298) | 2.90445026 |
| 71 | pore complex assembly (GO:0046931) | 2.90400701 |
| 72 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.90378619 |
| 73 | regulation of guanylate cyclase activity (GO:0031282) | 2.88572769 |
| 74 | positive regulation of humoral immune response (GO:0002922) | 2.88029265 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.87956390 |
| 76 | response to protozoan (GO:0001562) | 2.87356734 |
| 77 | negative regulation of histone methylation (GO:0031061) | 2.86012064 |
| 78 | synaptic vesicle exocytosis (GO:0016079) | 2.85412059 |
| 79 | positive regulation of immune response to tumor cell (GO:0002839) | 2.84190889 |
| 80 | regulation of immune response to tumor cell (GO:0002837) | 2.84190889 |
| 81 | regulation of response to tumor cell (GO:0002834) | 2.84190889 |
| 82 | positive regulation of response to tumor cell (GO:0002836) | 2.84190889 |
| 83 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.83762069 |
| 84 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.82550518 |
| 85 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80874325 |
| 86 | defense response to protozoan (GO:0042832) | 2.80817829 |
| 87 | locomotory exploration behavior (GO:0035641) | 2.80235007 |
| 88 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.79385834 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79098185 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.78642160 |
| 91 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75262407 |
| 92 | positive regulation of interleukin-10 production (GO:0032733) | 2.73647728 |
| 93 | regulation of B cell proliferation (GO:0030888) | 2.72796986 |
| 94 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72272057 |
| 95 | positive regulation of interleukin-12 production (GO:0032735) | 2.71810077 |
| 96 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.70611997 |
| 97 | visual perception (GO:0007601) | 2.69591648 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.68782433 |
| 99 | lymphocyte homeostasis (GO:0002260) | 2.68666144 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.67633124 |
| 101 | macrophage activation involved in immune response (GO:0002281) | 2.67581081 |
| 102 | regulation of T-helper cell differentiation (GO:0045622) | 2.66832979 |
| 103 | regulation of ARF protein signal transduction (GO:0032012) | 2.66700484 |
| 104 | cellular response to interferon-gamma (GO:0071346) | 2.66543898 |
| 105 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.66500696 |
| 106 | sensory perception of light stimulus (GO:0050953) | 2.66004542 |
| 107 | regulation of synaptic vesicle transport (GO:1902803) | 2.65847997 |
| 108 | protein localization to chromosome, centromeric region (GO:0071459) | 2.64315496 |
| 109 | dendritic cell differentiation (GO:0097028) | 2.63367207 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.63295089 |
| 111 | protein localization to synapse (GO:0035418) | 2.62738097 |
| 112 | regulation of integrin activation (GO:0033623) | 2.62260582 |
| 113 | regulation of vesicle fusion (GO:0031338) | 2.60954845 |
| 114 | cellular response to arsenic-containing substance (GO:0071243) | 2.60670141 |
| 115 | T cell costimulation (GO:0031295) | 2.60639794 |
| 116 | positive regulation of B cell mediated immunity (GO:0002714) | 2.60630313 |
| 117 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.60630313 |
| 118 | positive regulation of protein oligomerization (GO:0032461) | 2.60433602 |
| 119 | negative regulation of B cell proliferation (GO:0030889) | 2.60316239 |
| 120 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.58813649 |
| 121 | positive regulation of B cell proliferation (GO:0030890) | 2.58759174 |
| 122 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57649624 |
| 123 | cellular response to growth hormone stimulus (GO:0071378) | 2.57565094 |
| 124 | modulation by symbiont of host cellular process (GO:0044068) | 2.57283715 |
| 125 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57246546 |
| 126 | regulation of interferon-beta production (GO:0032648) | 2.57227804 |
| 127 | lymphocyte costimulation (GO:0031294) | 2.56065127 |
| 128 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.55601930 |
| 129 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.55041693 |
| 130 | regulation of macrophage cytokine production (GO:0010935) | 2.55021495 |
| 131 | positive regulation of interleukin-4 production (GO:0032753) | 2.54769480 |
| 132 | activation of Rac GTPase activity (GO:0032863) | 2.53428462 |
| 133 | mitotic sister chromatid cohesion (GO:0007064) | 2.52754255 |
| 134 | adaptation of signaling pathway (GO:0023058) | 2.41538451 |
| 135 | positive regulation of neurotransmitter transport (GO:0051590) | 2.36691453 |
| 136 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.35976868 |
| 137 | positive regulation of p38MAPK cascade (GO:1900745) | 2.35057908 |
| 138 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.33837866 |
| 139 | chemosensory behavior (GO:0007635) | 2.32986891 |
| 140 | myeloid dendritic cell differentiation (GO:0043011) | 2.31887069 |
| 141 | cellular potassium ion homeostasis (GO:0030007) | 2.30826627 |
| 142 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.29864539 |
| 143 | response to histamine (GO:0034776) | 2.29604353 |
| 144 | phospholipid homeostasis (GO:0055091) | 2.27775887 |
| 145 | positive regulation of membrane potential (GO:0045838) | 2.25950771 |
| 146 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.25880556 |
| 147 | long term synaptic depression (GO:0060292) | 2.25168404 |
| 148 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.24595645 |
| 149 | detection of external stimulus (GO:0009581) | 2.23753197 |
| 150 | lipoprotein transport (GO:0042953) | 2.23724759 |
| 151 | sodium ion export (GO:0071436) | 2.23504792 |
| 152 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.23435801 |
| 153 | regulation of postsynaptic membrane potential (GO:0060078) | 2.22782023 |
| 154 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.22122472 |
| 155 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.21882860 |
| 156 | eye photoreceptor cell differentiation (GO:0001754) | 2.18997791 |
| 157 | photoreceptor cell differentiation (GO:0046530) | 2.18997791 |
| 158 | fructose metabolic process (GO:0006000) | 2.17913977 |
| 159 | macroautophagy (GO:0016236) | 2.17630151 |
| 160 | detection of abiotic stimulus (GO:0009582) | 2.16040835 |
| 161 | neurotransmitter secretion (GO:0007269) | 2.15393307 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.13041223 |
| 163 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.12806280 |
| 164 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.11377348 |
| 165 | urea cycle (GO:0000050) | 2.10930405 |
| 166 | urea metabolic process (GO:0019627) | 2.10930405 |
| 167 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.10126861 |
| 168 | long-term synaptic potentiation (GO:0060291) | 2.08214420 |
| 169 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.04450227 |
| 170 | synaptic transmission, glutamatergic (GO:0035249) | 2.04046820 |
| 171 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.03550817 |
| 172 | signal complex assembly (GO:0007172) | 2.03344229 |
| 173 | positive regulation of vesicle fusion (GO:0031340) | 2.02845144 |
| 174 | vocalization behavior (GO:0071625) | 2.00771508 |
| 175 | positive regulation of cGMP biosynthetic process (GO:0030828) | 1.99409485 |
| 176 | response to muramyl dipeptide (GO:0032495) | 1.99226295 |
| 177 | phosphate ion transport (GO:0006817) | 1.98976101 |
| 178 | cAMP biosynthetic process (GO:0006171) | 1.98893946 |
| 179 | behavioral response to cocaine (GO:0048148) | 1.98686764 |
| 180 | regulation of synapse structural plasticity (GO:0051823) | 1.98327027 |
| 181 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.98098521 |
| 182 | positive regulation of antigen processing and presentation (GO:0002579) | 1.97665903 |
| 183 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 1.96701373 |
| 184 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 1.96387301 |
| 185 | synaptic vesicle endocytosis (GO:0048488) | 1.94555846 |
| 186 | neuron-neuron synaptic transmission (GO:0007270) | 1.94478395 |
| 187 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 1.92879045 |
| 188 | regulation of synaptic plasticity (GO:0048167) | 1.92737008 |
| 189 | nitrogen cycle metabolic process (GO:0071941) | 1.91746863 |
| 190 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 1.91269987 |
| 191 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.90515806 |
| 192 | regulation of neurotransmitter secretion (GO:0046928) | 1.90235566 |
| 193 | regulation of cGMP biosynthetic process (GO:0030826) | 1.89652673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.31076237 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.96580711 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.80543115 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.26083750 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.07865304 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.68731697 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39601263 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35093443 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.34557438 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 2.30958575 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20084734 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14938744 |
| 13 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.13714892 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.07697343 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.02349016 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00293881 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.00000010 |
| 18 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.98795523 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.98282686 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93942417 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93112769 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90914893 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88661803 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88587327 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87762993 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.86625279 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85146543 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83580485 |
| 29 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83548474 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80610421 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.79433569 |
| 32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.78151535 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75836342 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74413077 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74395844 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.73638180 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73307798 |
| 38 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70186593 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68679094 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68621855 |
| 41 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.68345028 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67417231 |
| 43 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66270103 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64511795 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.63454431 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60927364 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60492392 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59559075 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55185944 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.54576437 |
| 51 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.53187519 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51447888 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49942756 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49187805 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47094208 |
| 56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.47020171 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45002859 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44952232 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44902057 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44674797 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44608007 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44087939 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.43063318 |
| 64 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42713717 |
| 65 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41629026 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39135799 |
| 67 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.37487305 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37022411 |
| 69 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.36823589 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36812789 |
| 71 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35756820 |
| 72 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35756820 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35002619 |
| 74 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33949073 |
| 75 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33364035 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30133663 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30100849 |
| 78 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29824643 |
| 79 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28209784 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.27603037 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27048514 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26532916 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26240255 |
| 84 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25944258 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25842760 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25472358 |
| 87 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.24751360 |
| 88 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.23110155 |
| 89 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22215546 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22074861 |
| 91 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21964534 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21610646 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20264876 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19999637 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19856252 |
| 96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18656047 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17981612 |
| 98 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16731562 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16487369 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16082236 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14574091 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14546000 |
| 103 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14492173 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13995600 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13938140 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13779636 |
| 107 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13762472 |
| 108 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11927832 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11620239 |
| 110 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11515953 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09318430 |
| 112 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08368784 |
| 113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08355701 |
| 114 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08309693 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08109794 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07985947 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07909359 |
| 118 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07387392 |
| 119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07377709 |
| 120 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07097539 |
| 121 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07040466 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05595007 |
| 123 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05445491 |
| 124 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04155530 |
| 125 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03577287 |
| 126 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03432111 |
| 127 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03427111 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03205541 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02186297 |
| 130 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01624866 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01606274 |
| 132 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.01193986 |
| 133 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00450905 |
| 134 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99861067 |
| 135 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99811696 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99045541 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98690091 |
| 138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97283635 |
| 139 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.96892122 |
| 140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96720998 |
| 141 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96719549 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94661698 |
| 143 | AR_19668381_ChIP-Seq_PC3_Human | 0.93824155 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93681189 |
| 145 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93047783 |
| 146 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92788593 |
| 147 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.92507610 |
| 148 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92425449 |
| 149 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92382442 |
| 150 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92348351 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91180471 |
| 152 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90055527 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88850719 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88545526 |
| 155 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88545526 |
| 156 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88494175 |
| 157 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88395752 |
| 158 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88101254 |
| 159 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.87789292 |
| 160 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87649642 |
| 161 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86700213 |
| 162 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86469001 |
| 163 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85543319 |
| 164 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85120526 |
| 165 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84819520 |
| 166 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84233714 |
| 167 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84224968 |
| 168 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83960924 |
| 169 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83885919 |
| 170 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83195206 |
| 171 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.82740022 |
| 172 | AR_25329375_ChIP-Seq_VCAP_Human | 0.82038155 |
| 173 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81789631 |
| 174 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81660809 |
| 175 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80829873 |
| 176 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79557298 |
| 177 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.78626051 |
| 178 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77965272 |
| 179 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77349663 |
| 180 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77288278 |
| 181 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.77212855 |
| 182 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76406903 |
| 183 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.76353944 |
| 184 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74670519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.55409313 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 4.47280556 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.35686956 |
| 4 | MP0003011_delayed_dark_adaptation | 4.31464807 |
| 5 | MP0008057_abnormal_DNA_replication | 3.69920236 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.43293759 |
| 7 | MP0004510_myositis | 3.15849404 |
| 8 | MP0005671_abnormal_response_to | 2.98749684 |
| 9 | MP0005253_abnormal_eye_physiology | 2.81684558 |
| 10 | MP0005623_abnormal_meninges_morphology | 2.78556890 |
| 11 | MP0006072_abnormal_retinal_apoptosis | 2.53058809 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.48354152 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.39617250 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.24644867 |
| 15 | MP0002398_abnormal_bone_marrow | 2.20738975 |
| 16 | MP0002723_abnormal_immune_serum | 2.13573812 |
| 17 | MP0005451_abnormal_body_composition | 2.13443824 |
| 18 | MP0003111_abnormal_nucleus_morphology | 2.09942220 |
| 19 | MP0003091_abnormal_cell_migration | 2.08313764 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 1.99997727 |
| 21 | MP0003880_abnormal_central_pattern | 1.97545068 |
| 22 | MP0005310_abnormal_salivary_gland | 1.97503779 |
| 23 | MP0001348_abnormal_lacrimal_gland | 1.97410867 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.95676165 |
| 25 | MP0001819_abnormal_immune_cell | 1.93906493 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.91397663 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.90413213 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.89132599 |
| 29 | MP0005360_urolithiasis | 1.87433980 |
| 30 | MP0003077_abnormal_cell_cycle | 1.82952925 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.81190032 |
| 32 | MP0002090_abnormal_vision | 1.80420757 |
| 33 | MP0004270_analgesia | 1.78558868 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.77838665 |
| 35 | MP0000716_abnormal_immune_system | 1.77345316 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.74809863 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.73596666 |
| 38 | MP0005195_abnormal_posterior_eye | 1.65096594 |
| 39 | MP0002429_abnormal_blood_cell | 1.61373251 |
| 40 | MP0000685_abnormal_immune_system | 1.60020727 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.58881253 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.57448392 |
| 43 | MP0005025_abnormal_response_to | 1.56944745 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.56713519 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.56690971 |
| 46 | MP0005365_abnormal_bile_salt | 1.56627488 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.56566698 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.55254167 |
| 49 | MP0005085_abnormal_gallbladder_physiolo | 1.55163630 |
| 50 | MP0002722_abnormal_immune_system | 1.51843411 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.51720589 |
| 52 | MP0001324_abnormal_eye_pigmentation | 1.50996360 |
| 53 | MP0000350_abnormal_cell_proliferation | 1.49101490 |
| 54 | MP0003075_altered_response_to | 1.48711696 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.47210770 |
| 56 | MP0009745_abnormal_behavioral_response | 1.45735979 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.43304620 |
| 58 | MP0001346_abnormal_lacrimal_gland | 1.42895216 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.41750176 |
| 60 | MP0003436_decreased_susceptibility_to | 1.39666741 |
| 61 | MP0002229_neurodegeneration | 1.38601544 |
| 62 | MP0002064_seizures | 1.37275336 |
| 63 | MP0002822_catalepsy | 1.35659248 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.35301040 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.35245111 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.34690929 |
| 67 | MP0009046_muscle_twitch | 1.34567683 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.31285202 |
| 69 | MP0003252_abnormal_bile_duct | 1.30773737 |
| 70 | MP0003303_peritoneal_inflammation | 1.30194532 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.29465722 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 1.28442122 |
| 73 | MP0000858_altered_metastatic_potential | 1.28168920 |
| 74 | MP0002163_abnormal_gland_morphology | 1.25763351 |
| 75 | MP0003195_calcinosis | 1.23736985 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 1.23100217 |
| 77 | MP0002405_respiratory_system_inflammati | 1.21890970 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 1.21545773 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21043256 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.20447460 |
| 81 | MP0005535_abnormal_body_temperature | 1.20439536 |
| 82 | MP0010307_abnormal_tumor_latency | 1.20373613 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.19841086 |
| 84 | MP0001730_embryonic_growth_arrest | 1.19407185 |
| 85 | MP0001790_abnormal_immune_system | 1.18820961 |
| 86 | MP0005387_immune_system_phenotype | 1.18820961 |
| 87 | MP0002909_abnormal_adrenal_gland | 1.17916059 |
| 88 | MP0000604_amyloidosis | 1.17029210 |
| 89 | MP0005621_abnormal_cell_physiology | 1.16903587 |
| 90 | MP0005423_abnormal_somatic_nervous | 1.16349070 |
| 91 | MP0003879_abnormal_hair_cell | 1.16059520 |
| 92 | MP0001845_abnormal_inflammatory_respons | 1.14555180 |
| 93 | MP0001764_abnormal_homeostasis | 1.11426622 |
| 94 | MP0001765_abnormal_ion_homeostasis | 1.08496169 |
| 95 | MP0004043_abnormal_pH_regulation | 1.07751534 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 1.07403742 |
| 97 | MP0002019_abnormal_tumor_incidence | 1.07305542 |
| 98 | MP0000490_abnormal_crypts_of | 1.07274692 |
| 99 | MP0000313_abnormal_cell_death | 1.07162592 |
| 100 | MP0008961_abnormal_basal_metabolism | 1.05036355 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 1.04576000 |
| 102 | MP0002332_abnormal_exercise_endurance | 1.03961682 |
| 103 | MP0003045_fibrosis | 0.99816003 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.99383134 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.99125935 |
| 106 | MP0004858_abnormal_nervous_system | 0.98164511 |
| 107 | MP0009840_abnormal_foam_cell | 0.97626450 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.97067840 |
| 109 | MP0005391_vision/eye_phenotype | 0.96611561 |
| 110 | MP0002272_abnormal_nervous_system | 0.96099250 |
| 111 | MP0009764_decreased_sensitivity_to | 0.95097776 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94164808 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.93637111 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.93043501 |
| 115 | MP0005332_abnormal_amino_acid | 0.91809237 |
| 116 | MP0001486_abnormal_startle_reflex | 0.91714949 |
| 117 | MP0004130_abnormal_muscle_cell | 0.89872251 |
| 118 | MP0008874_decreased_physiological_sensi | 0.87600133 |
| 119 | MP0010329_abnormal_lipoprotein_level | 0.87297295 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.87277305 |
| 121 | MP0001853_heart_inflammation | 0.85313626 |
| 122 | MP0004885_abnormal_endolymph | 0.84597869 |
| 123 | MP0003646_muscle_fatigue | 0.84374322 |
| 124 | MP0003191_abnormal_cellular_cholesterol | 0.83710518 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.82795988 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.82338531 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.82338531 |
| 128 | MP0005000_abnormal_immune_tolerance | 0.82079465 |
| 129 | MP0003633_abnormal_nervous_system | 0.81559579 |
| 130 | MP0002419_abnormal_innate_immunity | 0.80820193 |
| 131 | MP0005384_cellular_phenotype | 0.79365204 |
| 132 | MP0009785_altered_susceptibility_to | 0.78582894 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.78207289 |
| 134 | MP0001968_abnormal_touch/_nociception | 0.77744809 |
| 135 | MP0002882_abnormal_neuron_morphology | 0.77074165 |
| 136 | MP0003984_embryonic_growth_retardation | 0.76337636 |
| 137 | MP0008872_abnormal_physiological_respon | 0.75822997 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.75761906 |
| 139 | MP0001697_abnormal_embryo_size | 0.75108214 |
| 140 | MP0002928_abnormal_bile_duct | 0.74503686 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.74127350 |
| 142 | MP0005166_decreased_susceptibility_to | 0.73458339 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.73271756 |
| 144 | MP0005645_abnormal_hypothalamus_physiol | 0.72994747 |
| 145 | MP0002009_preneoplasia | 0.72493032 |
| 146 | MP0002118_abnormal_lipid_homeostasis | 0.72038244 |
| 147 | MP0001851_eye_inflammation | 0.71643124 |
| 148 | MP0001440_abnormal_grooming_behavior | 0.71244368 |
| 149 | MP0005380_embryogenesis_phenotype | 0.71109783 |
| 150 | MP0001672_abnormal_embryogenesis/_devel | 0.71109783 |
| 151 | MP0002088_abnormal_embryonic_growth/wei | 0.70613123 |
| 152 | MP0005375_adipose_tissue_phenotype | 0.70277681 |
| 153 | MP0003329_amyloid_beta_deposits | 0.69326054 |
| 154 | MP0004947_skin_inflammation | 0.68792010 |
| 155 | MP0009672_abnormal_birth_weight | 0.68731355 |
| 156 | MP0000609_abnormal_liver_physiology | 0.68726620 |
| 157 | MP0002080_prenatal_lethality | 0.68185093 |
| 158 | MP0001533_abnormal_skeleton_physiology | 0.67897811 |
| 159 | MP0008260_abnormal_autophagy | 0.67745789 |
| 160 | MP0002734_abnormal_mechanical_nocicepti | 0.66150548 |
| 161 | MP0002006_tumorigenesis | 0.65583333 |
| 162 | MP0000230_abnormal_systemic_arterial | 0.65487075 |
| 163 | MP0002086_abnormal_extraembryonic_tissu | 0.64961062 |
| 164 | MP0001873_stomach_inflammation | 0.64683175 |
| 165 | MP0001800_abnormal_humoral_immune | 0.64545484 |
| 166 | MP0008569_lethality_at_weaning | 0.64295725 |
| 167 | MP0008007_abnormal_cellular_replicative | 0.62721420 |
| 168 | MP0003724_increased_susceptibility_to | 0.61831915 |
| 169 | MP0003448_altered_tumor_morphology | 0.61794385 |
| 170 | MP0003656_abnormal_erythrocyte_physiolo | 0.60217969 |
| 171 | MP0009278_abnormal_bone_marrow | 0.59975217 |
| 172 | MP0002089_abnormal_postnatal_growth/wei | 0.57708538 |
| 173 | MP0009763_increased_sensitivity_to | 0.57407616 |
| 174 | MP0004197_abnormal_fetal_growth/weight/ | 0.57219384 |
| 175 | MP0000733_abnormal_muscle_development | 0.57177357 |
| 176 | MP0000003_abnormal_adipose_tissue | 0.55740944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 8.08756273 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.61512351 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 6.43028404 |
| 4 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.40881063 |
| 5 | Central scotoma (HP:0000603) | 6.07756578 |
| 6 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.01178689 |
| 7 | Pigmentary retinal degeneration (HP:0001146) | 5.93370039 |
| 8 | Chorioretinal atrophy (HP:0000533) | 5.75548267 |
| 9 | IgA deficiency (HP:0002720) | 5.57447530 |
| 10 | Scotoma (HP:0000575) | 4.93840304 |
| 11 | Abnormality of macular pigmentation (HP:0008002) | 4.92409726 |
| 12 | Dyschromatopsia (HP:0007641) | 4.75992084 |
| 13 | Agammaglobulinemia (HP:0004432) | 4.64861828 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 4.56198015 |
| 15 | Pendular nystagmus (HP:0012043) | 4.42201612 |
| 16 | Recurrent viral infections (HP:0004429) | 4.12269819 |
| 17 | Emphysema (HP:0002097) | 4.00506456 |
| 18 | Decreased central vision (HP:0007663) | 3.97280429 |
| 19 | Posterior subcapsular cataract (HP:0007787) | 3.85277479 |
| 20 | Macular degeneration (HP:0000608) | 3.83798088 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 3.82607740 |
| 22 | Lymphopenia (HP:0001888) | 3.78334825 |
| 23 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.73496315 |
| 24 | Cellulitis (HP:0100658) | 3.66492044 |
| 25 | Recurrent sinusitis (HP:0011108) | 3.63877325 |
| 26 | Photophobia (HP:0000613) | 3.58280952 |
| 27 | Type II diabetes mellitus (HP:0005978) | 3.54736066 |
| 28 | Cone-rod dystrophy (HP:0000548) | 3.46542500 |
| 29 | Progressive visual loss (HP:0000529) | 3.44732040 |
| 30 | IgM deficiency (HP:0002850) | 3.42398910 |
| 31 | Constricted visual fields (HP:0001133) | 3.14357997 |
| 32 | Meningitis (HP:0001287) | 3.11869826 |
| 33 | Vasculitis (HP:0002633) | 3.11246558 |
| 34 | Choroideremia (HP:0001139) | 3.01817709 |
| 35 | Recurrent bronchitis (HP:0002837) | 2.98400578 |
| 36 | Focal motor seizures (HP:0011153) | 2.90004756 |
| 37 | Hyperacusis (HP:0010780) | 2.85947451 |
| 38 | Recurrent lower respiratory tract infections (HP:0002783) | 2.78466938 |
| 39 | Viral hepatitis (HP:0006562) | 2.78241346 |
| 40 | Persistence of primary teeth (HP:0006335) | 2.74749580 |
| 41 | Abnormal platelet volume (HP:0011876) | 2.74006268 |
| 42 | Squamous cell carcinoma (HP:0002860) | 2.73955111 |
| 43 | Severe visual impairment (HP:0001141) | 2.71981993 |
| 44 | Retinal atrophy (HP:0001105) | 2.71929499 |
| 45 | Increased mean platelet volume (HP:0011877) | 2.70113049 |
| 46 | Vitreoretinal degeneration (HP:0000655) | 2.68791122 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68010773 |
| 48 | Progressive external ophthalmoplegia (HP:0000590) | 2.65964395 |
| 49 | Restrictive lung disease (HP:0002091) | 2.64955028 |
| 50 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.61285723 |
| 51 | Thoracolumbar scoliosis (HP:0002944) | 2.58027888 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.57841662 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.56575714 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.56406187 |
| 55 | Increased IgE level (HP:0003212) | 2.53175157 |
| 56 | IgG deficiency (HP:0004315) | 2.50780965 |
| 57 | Lymphoma (HP:0002665) | 2.50630822 |
| 58 | Autoimmune hemolytic anemia (HP:0001890) | 2.49601868 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.46178075 |
| 60 | Retinitis pigmentosa (HP:0000510) | 2.45283361 |
| 61 | Epileptic encephalopathy (HP:0200134) | 2.43897629 |
| 62 | Increased IgM level (HP:0003496) | 2.43848620 |
| 63 | Increased corneal curvature (HP:0100692) | 2.41314565 |
| 64 | Keratoconus (HP:0000563) | 2.41314565 |
| 65 | Osteomyelitis (HP:0002754) | 2.40847952 |
| 66 | Subcapsular cataract (HP:0000523) | 2.38023538 |
| 67 | Febrile seizures (HP:0002373) | 2.37045551 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35597490 |
| 69 | Visual hallucinations (HP:0002367) | 2.33397448 |
| 70 | Insomnia (HP:0100785) | 2.27044632 |
| 71 | Abnormality of the periventricular white matter (HP:0002518) | 2.25243267 |
| 72 | Basal cell carcinoma (HP:0002671) | 2.22549271 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.22419809 |
| 74 | Petechiae (HP:0000967) | 2.20466098 |
| 75 | Xerostomia (HP:0000217) | 2.18804167 |
| 76 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.18661114 |
| 77 | Verrucae (HP:0200043) | 2.17464711 |
| 78 | Papilloma (HP:0012740) | 2.17464711 |
| 79 | Myokymia (HP:0002411) | 2.16666685 |
| 80 | Abnormality of the fingertips (HP:0001211) | 2.15331072 |
| 81 | Deep venous thrombosis (HP:0002625) | 2.14932278 |
| 82 | Hepatitis (HP:0012115) | 2.12888728 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.12194706 |
| 84 | Impaired proprioception (HP:0010831) | 2.11512395 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10892913 |
| 86 | B lymphocytopenia (HP:0010976) | 2.10078415 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.07630600 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.06600388 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 2.06600388 |
| 90 | Progressive muscle weakness (HP:0003323) | 2.06184052 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.04632684 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 2.04088986 |
| 93 | Focal seizures (HP:0007359) | 2.02381664 |
| 94 | Chronic otitis media (HP:0000389) | 2.02375445 |
| 95 | Tetraparesis (HP:0002273) | 2.00827190 |
| 96 | Leukopenia (HP:0001882) | 1.99449060 |
| 97 | Recurrent pneumonia (HP:0006532) | 1.97439701 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94819037 |
| 99 | Hypertensive crisis (HP:0100735) | 1.94629736 |
| 100 | Gout (HP:0001997) | 1.93442316 |
| 101 | Hyperkalemia (HP:0002153) | 1.93380906 |
| 102 | Absence seizures (HP:0002121) | 1.92714638 |
| 103 | Eczematoid dermatitis (HP:0000976) | 1.91588848 |
| 104 | Esophageal varix (HP:0002040) | 1.91361930 |
| 105 | Increased connective tissue (HP:0009025) | 1.90566518 |
| 106 | Hypoglycemic coma (HP:0001325) | 1.90208937 |
| 107 | Overriding aorta (HP:0002623) | 1.89694331 |
| 108 | Elfin facies (HP:0004428) | 1.88918182 |
| 109 | Polycythemia (HP:0001901) | 1.88715419 |
| 110 | Ketoacidosis (HP:0001993) | 1.88072202 |
| 111 | Termporal pattern (HP:0011008) | 1.87795764 |
| 112 | Insidious onset (HP:0003587) | 1.87795764 |
| 113 | Supranuclear gaze palsy (HP:0000605) | 1.87124767 |
| 114 | Long palpebral fissure (HP:0000637) | 1.85762777 |
| 115 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85469593 |
| 116 | Impaired platelet aggregation (HP:0003540) | 1.84684614 |
| 117 | Abnormal platelet function (HP:0011869) | 1.84684614 |
| 118 | Abnormality of the common coagulation pathway (HP:0010990) | 1.84481780 |
| 119 | Uterine leiomyosarcoma (HP:0002891) | 1.83743385 |
| 120 | Leiomyosarcoma (HP:0100243) | 1.83743385 |
| 121 | Poikiloderma (HP:0001029) | 1.82976073 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.82632329 |
| 123 | Abnormal pancreas size (HP:0012094) | 1.81295906 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.79487643 |
| 125 | Epistaxis (HP:0000421) | 1.79320412 |
| 126 | Recurrent bacterial skin infections (HP:0005406) | 1.78176348 |
| 127 | Amaurosis fugax (HP:0100576) | 1.77460696 |
| 128 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77396542 |
| 129 | Dysmetric saccades (HP:0000641) | 1.76526433 |
| 130 | Menorrhagia (HP:0000132) | 1.75834029 |
| 131 | Keratoconjunctivitis (HP:0001096) | 1.75781694 |
| 132 | Arthralgia (HP:0002829) | 1.75478778 |
| 133 | Ketosis (HP:0001946) | 1.75096041 |
| 134 | Short chin (HP:0000331) | 1.74927419 |
| 135 | Intrahepatic cholestasis (HP:0001406) | 1.74899845 |
| 136 | Atonic seizures (HP:0010819) | 1.74561851 |
| 137 | Postural instability (HP:0002172) | 1.74255983 |
| 138 | Progressive hearing impairment (HP:0001730) | 1.73084828 |
| 139 | Dialeptic seizures (HP:0011146) | 1.73023801 |
| 140 | Abnormality of macrophages (HP:0004311) | 1.72867901 |
| 141 | Symptomatic seizures (HP:0011145) | 1.72569621 |
| 142 | Hyperventilation (HP:0002883) | 1.72566493 |
| 143 | Generalized tonic-clonic seizures (HP:0002069) | 1.71464270 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.71400580 |
| 145 | Dysdiadochokinesis (HP:0002075) | 1.70216010 |
| 146 | Deep palmar crease (HP:0006191) | 1.69145319 |
| 147 | Cutaneous melanoma (HP:0012056) | 1.68763896 |
| 148 | Chronic diarrhea (HP:0002028) | 1.68761806 |
| 149 | Recurrent fungal infections (HP:0002841) | 1.68651700 |
| 150 | Encephalitis (HP:0002383) | 1.68454185 |
| 151 | Increased density of long bones (HP:0006392) | 1.68196699 |
| 152 | Colitis (HP:0002583) | 1.68084013 |
| 153 | Acute lymphatic leukemia (HP:0006721) | 1.65795700 |
| 154 | Xanthomatosis (HP:0000991) | 1.65238532 |
| 155 | Myocardial infarction (HP:0001658) | 1.64891798 |
| 156 | Prominent nose (HP:0000448) | 1.64747201 |
| 157 | Recurrent cutaneous fungal infections (HP:0011370) | 1.62726718 |
| 158 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.62726718 |
| 159 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.62633778 |
| 160 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.61709193 |
| 161 | Chin dimple (HP:0010751) | 1.61392427 |
| 162 | Syncope (HP:0001279) | 1.60992170 |
| 163 | Deep philtrum (HP:0002002) | 1.60893417 |
| 164 | Complement deficiency (HP:0004431) | 1.60153689 |
| 165 | Autoimmune thrombocytopenia (HP:0001973) | 1.60141611 |
| 166 | Recurrent skin infections (HP:0001581) | 1.60138100 |
| 167 | Thrombocytosis (HP:0001894) | 1.60004880 |
| 168 | Hematochezia (HP:0002573) | 1.59659766 |
| 169 | Congenital sensorineural hearing impairment (HP:0008527) | 1.58991329 |
| 170 | Abnormality of B cell number (HP:0010975) | 1.58968078 |
| 171 | Status epilepticus (HP:0002133) | 1.58437174 |
| 172 | Exercise-induced myalgia (HP:0003738) | 1.58053169 |
| 173 | Mediastinal lymphadenopathy (HP:0100721) | 1.57149736 |
| 174 | Epidermoid cyst (HP:0200040) | 1.56902659 |
| 175 | Cerebral hemorrhage (HP:0001342) | 1.54864775 |
| 176 | Hyperactive renin-angiotensin system (HP:0000841) | 1.54805259 |
| 177 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.54738716 |
| 178 | Abnormality of the lower motor neuron (HP:0002366) | 1.54714736 |
| 179 | Fatigue (HP:0012378) | 1.53835794 |
| 180 | Polar cataract (HP:0010696) | 1.53333579 |
| 181 | Acute hepatic failure (HP:0006554) | 1.49645165 |
| 182 | Truncal ataxia (HP:0002078) | 1.49502483 |
| 183 | Impaired social interactions (HP:0000735) | 1.48282838 |
| 184 | Abnormal social behavior (HP:0012433) | 1.48282838 |
| 185 | Depression (HP:0000716) | 1.48250616 |
| 186 | Skin nodule (HP:0200036) | 1.48174060 |
| 187 | Abnormality of purine metabolism (HP:0004352) | 1.47709817 |
| 188 | Lower limb hyperreflexia (HP:0002395) | 1.47186745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.26034210 |
| 2 | MAP3K13 | 3.50680955 |
| 3 | EPHA4 | 3.30571150 |
| 4 | SMG1 | 2.97536070 |
| 5 | GRK1 | 2.78876669 |
| 6 | MAP4K1 | 2.55244263 |
| 7 | INSRR | 2.46525167 |
| 8 | NEK9 | 2.42819732 |
| 9 | RIPK4 | 2.33272813 |
| 10 | DAPK2 | 2.28031034 |
| 11 | NTRK3 | 2.27765689 |
| 12 | EEF2K | 2.09471173 |
| 13 | CDC7 | 1.99203921 |
| 14 | MAP3K9 | 1.95346778 |
| 15 | TBK1 | 1.73096040 |
| 16 | STK24 | 1.71390486 |
| 17 | BRD4 | 1.71116765 |
| 18 | PRKD3 | 1.65423365 |
| 19 | IKBKB | 1.65250042 |
| 20 | JAK1 | 1.64346888 |
| 21 | EIF2AK3 | 1.64174925 |
| 22 | CHUK | 1.63554528 |
| 23 | PRKAA2 | 1.63420557 |
| 24 | KSR2 | 1.62087066 |
| 25 | SIK2 | 1.56854317 |
| 26 | PINK1 | 1.55116949 |
| 27 | MAP3K7 | 1.54569390 |
| 28 | IKBKE | 1.54157650 |
| 29 | TYK2 | 1.52132336 |
| 30 | FGFR4 | 1.37492322 |
| 31 | CDK4 | 1.32202081 |
| 32 | TAOK2 | 1.28274602 |
| 33 | NME2 | 1.25779655 |
| 34 | PASK | 1.25729996 |
| 35 | EPHB1 | 1.23539260 |
| 36 | MAP3K10 | 1.22775970 |
| 37 | TAOK3 | 1.21554776 |
| 38 | SGK3 | 1.19353221 |
| 39 | SGK1 | 1.18778472 |
| 40 | MAP3K2 | 1.17072419 |
| 41 | BMPR2 | 1.16263203 |
| 42 | MAP2K4 | 1.15102594 |
| 43 | SGK2 | 1.14621336 |
| 44 | PAK6 | 1.14387203 |
| 45 | LATS2 | 1.13459202 |
| 46 | CAMKK1 | 1.12732414 |
| 47 | FGFR3 | 1.12306978 |
| 48 | MAP3K4 | 1.11625552 |
| 49 | ALK | 1.08764254 |
| 50 | JAK3 | 1.07717137 |
| 51 | GRK5 | 1.07139719 |
| 52 | SGK494 | 1.06737866 |
| 53 | SGK223 | 1.06737866 |
| 54 | STK38 | 1.06481656 |
| 55 | RIPK1 | 1.05856540 |
| 56 | TTN | 1.05618839 |
| 57 | RET | 1.04766266 |
| 58 | DDR2 | 1.01923803 |
| 59 | MAP3K1 | 1.01710080 |
| 60 | CSF1R | 0.99173534 |
| 61 | STK10 | 0.95499925 |
| 62 | MATK | 0.94569332 |
| 63 | TAF1 | 0.94186358 |
| 64 | KIT | 0.94179706 |
| 65 | BTK | 0.93095132 |
| 66 | MELK | 0.92511210 |
| 67 | MAPK11 | 0.92483153 |
| 68 | PIM1 | 0.91569231 |
| 69 | EPHA3 | 0.91347145 |
| 70 | JAK2 | 0.91133377 |
| 71 | MAP2K7 | 0.90816119 |
| 72 | MAP3K8 | 0.90681464 |
| 73 | DAPK1 | 0.89601594 |
| 74 | BLK | 0.87548995 |
| 75 | PRKCZ | 0.86210129 |
| 76 | PIM2 | 0.85823184 |
| 77 | PKN1 | 0.85621816 |
| 78 | BUB1 | 0.85463514 |
| 79 | PTK2B | 0.85032240 |
| 80 | STK11 | 0.84782544 |
| 81 | PTK6 | 0.84105353 |
| 82 | FES | 0.82639307 |
| 83 | CDK5 | 0.81079742 |
| 84 | KSR1 | 0.80435629 |
| 85 | PDGFRA | 0.79702516 |
| 86 | STK3 | 0.79278326 |
| 87 | FRK | 0.78264750 |
| 88 | CDK9 | 0.77322356 |
| 89 | RPS6KB2 | 0.76884363 |
| 90 | PRKCH | 0.75898211 |
| 91 | MAPK12 | 0.75889269 |
| 92 | IRAK2 | 0.74496154 |
| 93 | BMX | 0.72795949 |
| 94 | CDK19 | 0.72565964 |
| 95 | NTRK1 | 0.71832388 |
| 96 | PDPK1 | 0.71638406 |
| 97 | HIPK2 | 0.70881568 |
| 98 | MAPK7 | 0.69502000 |
| 99 | PDK1 | 0.69074804 |
| 100 | PRKAA1 | 0.67637920 |
| 101 | BRAF | 0.65239256 |
| 102 | CAMK4 | 0.64653541 |
| 103 | MAP2K3 | 0.62570999 |
| 104 | IRAK1 | 0.61878324 |
| 105 | CDK12 | 0.61754048 |
| 106 | MTOR | 0.61345242 |
| 107 | MINK1 | 0.60771547 |
| 108 | IRAK3 | 0.59773152 |
| 109 | CHEK1 | 0.59373696 |
| 110 | AKT3 | 0.57583879 |
| 111 | LYN | 0.56961676 |
| 112 | CAMK2A | 0.55977724 |
| 113 | DAPK3 | 0.55288670 |
| 114 | STK4 | 0.53991924 |
| 115 | CAMK1 | 0.53556180 |
| 116 | WNK1 | 0.53403946 |
| 117 | PRKACG | 0.53026493 |
| 118 | SIK1 | 0.52888297 |
| 119 | PAK3 | 0.52709933 |
| 120 | ERN1 | 0.52631891 |
| 121 | CDC42BPA | 0.52508076 |
| 122 | CSK | 0.51371687 |
| 123 | MAPK4 | 0.50822652 |
| 124 | MARK2 | 0.49616569 |
| 125 | WNK4 | 0.48175734 |
| 126 | SYK | 0.48171654 |
| 127 | RPS6KA3 | 0.47817567 |
| 128 | TRPM7 | 0.47393347 |
| 129 | PRKCE | 0.47201649 |
| 130 | CDK6 | 0.46891456 |
| 131 | PLK2 | 0.46352785 |
| 132 | SIK3 | 0.45366144 |
| 133 | TRIB3 | 0.45316783 |
| 134 | YES1 | 0.44593518 |
| 135 | ICK | 0.43585136 |
| 136 | PTK2 | 0.43567328 |
| 137 | GRK6 | 0.43299060 |
| 138 | FLT3 | 0.43062944 |
| 139 | SCYL2 | 0.42747197 |
| 140 | PRKCI | 0.42454152 |
| 141 | CCNB1 | 0.41015440 |
| 142 | DYRK1B | 0.40978530 |
| 143 | FGR | 0.40634090 |
| 144 | IRAK4 | 0.40367755 |
| 145 | ROCK2 | 0.40134773 |
| 146 | TEC | 0.39838492 |
| 147 | CHEK2 | 0.38289469 |
| 148 | MAP3K5 | 0.37871866 |
| 149 | HCK | 0.37346125 |
| 150 | ARAF | 0.37145360 |
| 151 | TTK | 0.36616843 |
| 152 | CDK8 | 0.36547788 |
| 153 | PRKCB | 0.36458758 |
| 154 | CDK7 | 0.36253618 |
| 155 | NEK1 | 0.35708523 |
| 156 | PRKCG | 0.35493401 |
| 157 | PRPF4B | 0.35469278 |
| 158 | CAMK1G | 0.35339997 |
| 159 | DMPK | 0.35179630 |
| 160 | MST4 | 0.34311379 |
| 161 | PRKCQ | 0.33121438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.24934537 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.82927888 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.77006487 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58170625 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.39144120 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39009129 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.03761627 |
| 8 | Influenza A_Homo sapiens_hsa05164 | 2.01222221 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.94208038 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.92175935 |
| 11 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.88943755 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84014370 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73028448 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.72948902 |
| 15 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.56729150 |
| 16 | Hepatitis B_Homo sapiens_hsa05161 | 1.54162173 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.54084737 |
| 18 | Apoptosis_Homo sapiens_hsa04210 | 1.49462987 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.49129728 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.48462224 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.44255608 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41409525 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39195854 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.37280910 |
| 25 | Hepatitis C_Homo sapiens_hsa05160 | 1.33813653 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33734736 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31594979 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31058889 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.26629092 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.25832903 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25811316 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25562936 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24798798 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24175427 |
| 35 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.23404074 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.18489909 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16866397 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15487567 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14048705 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10456538 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08927537 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08697805 |
| 43 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05872153 |
| 44 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05401528 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01367683 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00811567 |
| 47 | Prostate cancer_Homo sapiens_hsa05215 | 0.98212232 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97752570 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97621139 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 0.96178467 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 0.95011929 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94717779 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.93964815 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93132604 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91889230 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91856903 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90919426 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.90419685 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 0.90351649 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.90014324 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87279462 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86861209 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86844006 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86403302 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.86124072 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85881318 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85736388 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85468551 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84998608 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84946332 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84873832 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84160431 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84117141 |
| 74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83089620 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82710138 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 0.82387790 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80796222 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80705063 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.80409983 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80177123 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80133193 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79139208 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.78702291 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78645491 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75582545 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75407774 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74934130 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74693407 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73625899 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71737187 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71294376 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70614076 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.70142536 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70043236 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69837928 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69177732 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68449536 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68255007 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67200066 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66758468 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66708967 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66647990 |
| 103 | Allograft rejection_Homo sapiens_hsa05330 | 0.65090589 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64622236 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63714024 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63141528 |
| 107 | Spliceosome_Homo sapiens_hsa03040 | 0.63126826 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62939449 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62597169 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62051651 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61863109 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61331271 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61283927 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60932520 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60740219 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60601295 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60597374 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59981538 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.59232012 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57186929 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57023024 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56230819 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56148855 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56116647 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55108866 |
| 126 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.54477899 |
| 127 | Taste transduction_Homo sapiens_hsa04742 | 0.54219054 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53698232 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53282351 |
| 130 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52805455 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52344680 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51001365 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50753149 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50504883 |
| 135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49725398 |
| 136 | Base excision repair_Homo sapiens_hsa03410 | 0.48191335 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47306685 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.46852862 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46165401 |
| 140 | RNA transport_Homo sapiens_hsa03013 | 0.45969520 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.45585274 |
| 142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44666884 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.43797487 |
| 144 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43775522 |
| 145 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43055965 |
| 146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42904924 |
| 147 | Focal adhesion_Homo sapiens_hsa04510 | 0.42340470 |
| 148 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41306520 |
| 149 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40934836 |
| 150 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40124554 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39367204 |
| 152 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37714317 |
| 153 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36730069 |
| 154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36424051 |
| 155 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36090655 |
| 156 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35933629 |
| 157 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35796378 |
| 158 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35750859 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35603610 |
| 160 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35196272 |
| 161 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34174887 |
| 162 | Pertussis_Homo sapiens_hsa05133 | 0.33928203 |
| 163 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33521380 |
| 164 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33351764 |
| 165 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32425805 |
| 166 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31514414 |

